A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

Study Identifier
M06-889
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Study Drug
  • ABT-089
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 60 Years

    Protocol Summary

    The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with ADHD.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 6109
    Mesa, Arizona, United States, 85210
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6765
    Mesa, Arizona, United States, 85210
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6100
    Lafayette, California, United States, 94549
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6107
    San Diego, California, United States, 92103-8620
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6112
    Jacksonville, Florida, United States, 32216
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6096
    Maitland, Florida, United States, 32751
    Status
    Not applicable
    Showing {first} - {last} of {total} Results